Bharathi Mohan, P., U. K. Chapa, R. K. Chittoria, V. Chavan, A. Aggarwal, S. Gupta, C. L. Reddy, I. Pathan, and S. Koliyath. Role of phenytoin in diabetic foot ulcers. J. Cutan. Aesthet. Surg. 13:222–225, 2020.
Chen, L., L. Zheng, J. Jiang, J. Gui, L. Zhang, Y. Huang, X. Chen, J. Ji, and Y. Fan. Calcium hydroxide-induced proliferation, migration, osteogenic differentiation, and mineralization via the mitogen-activated protein kinase pathway in human dental pulp stem cells. J. Endod. 42:1355–1361, 2016.
Chow, K. M., and C. C. Szeto. Cerebral atrophy and skull thickening due to chronic phenytoin therapy. Can. Med. Assoc. J. 176:321–323, 2007.
Correa, J. D., C. M. Queiroz-Junior, J. E. Costa, A. L. Teixeira, and T. A. Silva. Phenytoin-induced gingival overgrowth: a review of the molecular, immune, and inflammatory features. ISRN Dent. 2011:497850, 2011.
Doshi, A., J. W. McAuley, and D. N. Tatakis. Topical phenytoin effects on palatal wound healing. J Periodontol. 92(3):409–418, 2020.
Gu, H., Z. Huang, X. Yin, J. Zhang, L. Gong, J. Chen, K. Rong, J. Xu, L. Lu, and L. Cui. Role of c-Jun N-terminal kinase in the osteogenic and adipogenic differentiation of human adipose-derived mesenchymal stem cells. Exp. Cell Res. 339:112–121, 2015.
Hains, B. C., C. Y. Saab, A. C. Lo, and S. G. Waxman. Sodium channel blockade with phenytoin protects spinal cord axons, enhances axonal conduction, and improves functional motor recovery after contusion SCI. Exp. Neurol. 188:365–377, 2004.
Hassell, T. M., R. C. Page, A. S. Narayanan, and C. G. Cooper. Diphenylhydantoin (dilantin) gingival hyperplasia: drug-induced abnormality of connective tissue. Proc. Natl. Acad. Sci. USA. 73:2909–2912, 1976.
Hesselink, J. M. K., and D. J. Kopsky. Phenytoin: 80 years young, from epilepsy to breast cancer, a remarkable molecule with multiple modes of action. J. Neurol. 264:1617–1621, 2017.
Hu, L., Y. Liu, and S. Wang. Stem cell-based tooth and periodontal regeneration. Oral Dis. 24:696–705, 2018.
Huang, C., Z. Rajfur, C. Borchers, M. D. Schaller, and K. Jacobson. JNK phosphorylates paxillin and regulates cell migration. Nature. 424:219–223, 2003.
Ikedo, D., K. Ohishi, N. Yamauchi, M. Kataoka, J. Kido, and T. Nagata. Stimulatory effects of phenytoin on osteoblastic differentiation of fetal rat calvaria cells in culture. Bone. 25:653–660, 1999.
Isaka, J., A. Ohazama, M. Kobayashi, C. Nagashima, T. Takiguchi, H. Kawasaki, T. Tachikawa, and K. Hasegawa. Participation of periodontal ligament cells with regeneration of alveolar bone. J. Periodontol. 72:314–323, 2001.
Janakiram, C., and B. A. Dye. A public health approach for prevention of periodontal disease. Periodontol. 2000(84):202–214, 2020.
Johnson, G. L., and R. Lapadat. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science. 298:1911–1912, 2002.
Kataoka, M., J. Kido, Y. Shinohara, and T. Nagata. Drug-induced gingival overgrowth—a review. Biol. Pharm. Bull. 28:1817–1821, 2005.
Kato, T., N. Okahashi, S. Kawai, T. Kato, H. Inaba, I. Morisaki, and A. Amano. Impaired degradation of matrix collagen in human gingival fibroblasts by the antiepileptic drug phenytoin. J. Periodontol. 76:941–950, 2005.
Kato, T., N. Okahashi, T. Ohno, H. Inaba, S. Kawai, and A. Amano. Effect of phenytoin on collagen accumulation by human gingival fibroblasts exposed to TNF-alpha in vitro. Oral Dis. 12:156–162, 2006.
Kim, H. Y., S. Y. Park, and S. Y. Choung. Enhancing effects of myricetin on the osteogenic differentiation of human periodontal ligament stem cells via BMP-2/Smad and ERK/JNK/p38 mitogen-activated protein kinase signaling pathway. Eur. J. Pharmacol. 834:84–91, 2018.
Klemke, R. L., S. Cai, A. L. Giannini, P. J. Gallagher, P. de Lanerolle, and D. A. Cheresh. Regulation of cell motility by mitogen-activated protein kinase. J. Cell Biol. 137:481–492, 1997.
Li, L., M. X. Han, S. Li, Y. Xu, and L. Wang. Hypoxia regulates the proliferation and osteogenic differentiation of human periodontal ligament cells under cyclic tensile stress via mitogen-activated protein kinase pathways. J. Periodontol. 85:498–508, 2014.
Lopez-Gonzalez, M. J., E. Luis, O. Fajardo, V. Meseguer, K. Gers-Barlag, S. Ninerola, and F. Viana. TRPA1 channels mediate human gingival fibroblast response to phenytoin. J. Dent. Res. 96:832–839, 2017.
Manokawinchoke, J., P. Sumrejkanchanakij, L. Boonprakong, P. Pavasant, H. Egusa, and T. Osathanon. NOTCH2 participates in Jagged1-induced osteogenic differentiation in human periodontal ligament cells. Sci. Rep. 10:13329, 2020.
Mohammed, F. H., M. A. Khajah, M. Yang, W. J. Brackenbury, and Y. A. Luqmani. Blockade of voltage-gated sodium channels inhibits invasion of endocrine-resistant breast cancer cells. Int. J. Oncol. 48:73–83, 2016.
Nakade, O., D. J. Baylink, and K. H. Lau. Phenytoin at micromolar concentrations is an osteogenic agent for human-mandible-derived bone cells in vitro. J. Dent. Res. 74:331–337, 1995.
Nikolov, A., N. Popovski, and I. Hristova. Collagenases MMP-1, MMP-13, and tissue inhibitors TIMP-1, TIMP-2: their role in healthy and complicated pregnancy and potential as preeclampsia biomarkers—a brief review. Appl. Sci. 10:7731, 2020.
Nunez, J., F. Vignoletti, R. G. Caffesse, and M. Sanz. Cellular therapy in periodontal regeneration. Periodontol. 2000(79):107–116, 2019.
Ohta, T., J. E. Wergedal, H. E. Gruber, D. J. Baylink, and K. H. Lau. Low dose phenytoin is an osteogenic agent in the rat. Calcif. Tissue Int. 56:42–48, 1995.
Olsen, C. M., E. T. Meussen-Elholm, L. S. Roste, and E. Tauboll. Antiepileptic drugs inhibit cell growth in the human breast cancer cell line MCF7. Mol. Cell Endocrinol. 213:173–179, 2004.
Patejdl, R., A. C. Leroux, and T. Noack. Phenytoin inhibits contractions of rat gastrointestinal and portal vein smooth muscle by inhibiting calcium entry. Neurogastroenterol. Motil. 27:1453–1465, 2015.
Patsalos, P. N., D. J. Berry, B. F. Bourgeois, J. C. Cloyd, T. A. Glauser, S. I. Johannessen, I. E. Leppik, T. Tomson, and E. Perucca. Antiepileptic drugs–best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies. Epilepsia. 49:1239–1276, 2008.
Sanchez, A. B., K. E. Medders, R. Maung, P. Sanchez-Pavon, D. Ojeda-Juarez, and M. Kaul. CXCL12-induced neurotoxicity critically depends on NMDA receptor-gated and L-type Ca2+ channels upstream of p38 MAPK. J. Neuroinflamm. 13:1–12, 2016.
Sano, M., N. Ohuchi, T. Inoue, K. Tono, T. Tachikawa, Y. Kizawa, and H. Murakami. Proliferative response to phenytoin and nifedipine in gingival fibroblasts cultured from humans with gingival fibromatosis. Fundam. Clin. Pharmacol. 18:465–470, 2004.
Sapna, G., S. Gokul, and K. Bagri-Manjrekar. Matrix metalloproteinases and periodontal diseases. Oral Dis. 20:538–550, 2014.
Schrader, L. A., S. G. Birnbaum, B. M. Nadin, Y. J. Ren, D. Bui, A. E. Anderson, and J. D. Sweatt. ERK/MAPK regulates the Kv4.2 potassium channel by direct phosphorylation of the pore-forming subunit. Am. J. Physiol. 290:C852–C861, 2006.
Subramaniam, T., M. B. Fauzi, Y. Lokanathan, and J. X. Law. The role of calcium in wound healing. Int. J. Mol. Sci. 22:6486, 2021.
Takeuchi, R., H. Matsumoto, Y. Akimoto, and A. Fujii. Inhibition of G(1) cell cycle arrest in human gingival fibroblasts exposed to phenytoin. Fundam. Clin. Pharmacol. 28:114–119, 2014.
Tang, M., Z. Peng, Z. Mai, L. Chen, Q. Mao, Z. Chen, Q. Chen, L. Liu, Y. Wang, and H. Ai. Fluid shear stress stimulates osteogenic differentiation of human periodontal ligament cells via the extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase signaling pathways. J. Periodontol. 85:1806–1813, 2014.
Teo, S. Y., M. Y. Yew, S. Y. Lee, M. J. Rathbone, S. N. Gan, and A. G. A. Coombes. In vitro evaluation of novel phenytoin-loaded alkyd nanoemulsions designed for application in topical wound healing. J. Pharm. Sci. 106:377–384, 2017.
Tomokiyo, A., N. Wada, and H. Maeda. Periodontal ligament stem cells: regenerative potency in periodontium. Stem Cells Dev. 28:974–985, 2019.
Trubiani, O., G. D. Marconi, S. D. Pierdomenico, A. Piattelli, F. Diomede, and J. Pizzicannella. Human oral stem cells, biomaterials and extracellular vesicles: a promising tool in bone tissue repair. Int. J. Mol. Sci. 20:4987, 2019.
Vijayasingham, S. M., P. J. Dykes, and R. Marks. Phenytoin has little effect on in-vitro models of wound healing. Br. J. Dermatol. 125:136–139, 1991.
Wittmack, E. K., A. M. Rush, A. Hudmon, S. G. Waxman, and S. D. Dib-Hajj. Voltage-gated sodium channel Na(v)1.6 is modulated by p38 mitogen-activated protein kinase. J. Neurosci. 25:6621–6630, 2005.
Yamamoto, T., Y. Ugawa, M. Kawamura, K. Yamashiro, S. Kochi, H. Ideguchi, and S. Takashiba. Modulation of microenvironment for controlling the fate of periodontal ligament cells: the role of Rho/ROCK signaling and cytoskeletal dynamics. J. Cell Commun. Signal. 12:369–378, 2018.
Yu, M. J., P. S. Yang, and S. H. Ge. Biological effects of phenytoin on cultured human periodontal ligament fibroblasts in vitro. Hua Xi Kou Qiang Yi Xue Za Zhi. 26:215–218, 2008.
Zheng, L., Y. Huang, W. Song, X. Gong, M. Liu, X. Jia, G. Zhou, L. Chen, A. Li, and Y. Fan. Fluid shear stress regulates metalloproteinase-1 and 2 in human periodontal ligament cells: involvement of extracellular signal-regulated kinase (ERK) and P38 signaling pathways. J. Biomech. 45:2368–2375, 2012.
Zheng, L. S., L. P. Chen, Y. C. Chen, J. P. Gui, Q. Li, Y. Huang, M. L. Liu, X. L. Jia, W. Song, J. Ji, et al. The effects of fluid shear stress on proliferation and osteogenesis of human periodontal ligament cells. J. Biomech. 49:572–579, 2016.